Health ❯ Healthcare ❯ Pharmaceuticals ❯ Medications

Weight Loss Drugs

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Investors focus on Lilly’s reliance on two injections for more than half of 2025 sales.

Lilly’s Triple‑Agonist Retatrutide Delivers Up to 28.7% Weight Loss in Phase 3, Easing Knee Pain

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide